These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 741458)

  • 21. Enhanced platelet aggregability in dogs following myocardial infarction.
    Fleming JS; Buyniski JP
    Life Sci; 1977 Mar; 20(5):843-8. PubMed ID: 15714769
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone].
    Gastpar H
    Fortschr Med; 1978 Sep; 96(36):1823-7. PubMed ID: 700559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.
    Cerskus AL; Ali M; McDonald JW
    Thromb Res; 1980 Jun; 18(5):693-705. PubMed ID: 7414555
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of antianginal drugs on platelet aggregation of rabbits.
    Takano S; Anzai T; Ogawa J; Suzuki T
    Fukushima J Med Sci; 1980 Jun; 27(1-2):25-9. PubMed ID: 6800909
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulphinpyrazone inhibits platelet function and enhances blood fibrinolytic activity in the rat.
    Hussaini IM; Moore PK
    Thromb Res; 1988 Nov; 52(4):337-41. PubMed ID: 3201405
    [No Abstract]   [Full Text] [Related]  

  • 27. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo.
    Pay GF; Wallis RB; Zelaschi D
    Haemostasis; 1981; 10(3):165-75. PubMed ID: 7262645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of sulfinpyrazone and naproxen on infarct size in the dog.
    Bolli R; Goldstein RE; Davenport N; Epstein SE
    Am J Cardiol; 1981 Apr; 47(4):841-7. PubMed ID: 7211698
    [No Abstract]   [Full Text] [Related]  

  • 30. An in vitro method for platelet morphological studies employing a reconstituted collagen substrate.
    Albert EN; Daniel RE; Whiting JD; Bailey JM
    Scan Electron Microsc; 1979; (3):131-8. PubMed ID: 392702
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relationship between inhibitory effect of anti-platelet drugs on platelet aggregation and clinical value (author's transl)].
    Yasunaga K; Kanzaki M
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):552-3. PubMed ID: 495017
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of sulfinpyrazone on treadmill exercise-induced angina pectoris.
    Lewis HD; Davis JW; Hassanein KM
    Cardiology; 1993; 83(4):228-33. PubMed ID: 8281538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-platelet aggregation therapy in vascular microsurgery: experimental study with sulfinpyrazone].
    Gaspari A; Ortensi A; Lania M; Ipri D; Busatta D
    Ann Ital Chir; 1983; 55(1):89-94. PubMed ID: 6651058
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyrazolidine derivatives: a comparative study of their effects on platelet aggregation.
    Cepelák V; Cepeláková H; Brůnová B; Kuchar M; Roubal Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):839-48. PubMed ID: 94876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfinpyrazone and platelet function in hypertensive patients.
    Davi G; Novo S; Gullotti D; Avellone G; Sofia MA; Strano A
    Thromb Haemost; 1984 Jul; 51(3):413. PubMed ID: 6388015
    [No Abstract]   [Full Text] [Related]  

  • 36. Alteration of the response of platelets to surface stimuli by pyrazole compounds.
    Packham MA; Warrior ES; Glynn MF; Senyi AS; Mustard JF
    J Exp Med; 1967 Jul; 126(1):171-88. PubMed ID: 4165501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sulfinpyrazone and aspirin in experimental microthrombosis].
    Villaverde CA; Hernández MR; Escolar G; Almirall L; Borruel MT
    Arch Farmacol Toxicol; 1981 Apr; 7(1):7-10. PubMed ID: 7325718
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
    Ali M; McDonald JW
    J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification and possible mechanisms of action of some drugs that inhibit platelet aggregation.
    Holmsen H
    Ser Haematol; 1975; 8(3):50-80. PubMed ID: 185725
    [No Abstract]   [Full Text] [Related]  

  • 40. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.